secwatch / observer
8-K filed June 16, 2023, 7:59 PM ET ticker ANVS CIK 0001477845
other confidence high sentiment neutral materiality 0.40

Annovis Bio shareholders approve doubling authorized common stock to 70M shares at annual meeting

Annovis Bio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Annovis Bio, Inc.: Amended certificate of incorporation to increase authorized common shares from 35,000,000 to 70,000,000 (effective 2023-06-15).

Change
charter amendment
Effective
2023-06-15
Exact text from the filing
At the Annual Meeting, among other things, the stockholders of the Company approved an amendment to the Annovis Bio, Inc. Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 35,000,000 to 70,000,000 shares (the “Charter Amendment’).
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Annovis Bio, Inc. shareholders approved Election of Directors at the 2023-06-16 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-16
Exact text from the filing
The following director nominees were elected to serve as directors of the Company, with the following votes tabulated: For Withheld Broker Non-Vote Michael Hoffman 3,994,452 40,827 2,307,303 Maria Maccecchini 3,998,045 37,234 2,307,303 Claudine Bruck 3,941,691 93,588 2,307,303 Reid McCarthy 3,993,879 41,400 2,307,303 Mark White 3,987,711 47,568 2,307,303
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Annovis Bio, Inc. shareholders approved Amendment of the 2020 Equity Incentive Plan to increase authorized shares from 35,000,000 to 70,000,000 at the 2023-06-16 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-06-16
Exact text from the filing
The amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 35,000,000 to 70,000,000 was approved, with the following votes tabulated: For Against Abstain 5,699,648 633,577 9,357
View on SEC.gov

Browse all governance changes →

Annovis Bio, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-072250
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.